Pfizer and BioNTech offered to supply South Africa with their Covid-19 vaccine at a discounted $10 a dose, according to a person familiar with the talks, yet the president’s office still described the cost as prohibitive. The price was worked out according to South Africa’s status as a middle-income nation and is about half of what the drugmakers are charging in the US, the person said, asking not to be identified as the information hasn’t been made public.
from Engineering News | Home https://ift.tt/3pTESM3
